S Staszewski

1.0k total citations
25 papers, 494 citations indexed

About

S Staszewski is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, S Staszewski has authored 25 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 12 papers in Virology and 10 papers in Epidemiology. Recurrent topics in S Staszewski's work include HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (12 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). S Staszewski is often cited by papers focused on HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (12 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). S Staszewski collaborates with scholars based in Germany, United States and Switzerland. S Staszewski's co-authors include HR Brodt, W. Stille, Vincent Launay‐Vacher, Jean‐Sébastien Hulot, Andrew Cheng, Daniel Vittecoq, Joel E. Gallant, Hassane Izzedine, Gilbert Deray and Randi Y. Leavitt and has published in prestigious journals such as JAMA, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

S Staszewski

24 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Staszewski Germany 8 393 268 221 96 35 25 494
Amit C. Achhra Australia 13 330 0.8× 226 0.8× 297 1.3× 89 0.9× 31 0.9× 26 485
Maria Vittoria Cossu Italy 15 387 1.0× 344 1.3× 141 0.6× 114 1.2× 55 1.6× 55 641
Laurie Myers United States 8 656 1.7× 454 1.7× 533 2.4× 123 1.3× 25 0.7× 8 899
Marilyn McMurchie Australia 6 297 0.8× 241 0.9× 94 0.4× 84 0.9× 14 0.4× 11 447
J.L. Pellegrin France 12 208 0.5× 128 0.5× 123 0.6× 101 1.1× 50 1.4× 27 463
Michael Giordano United States 6 502 1.3× 389 1.5× 292 1.3× 48 0.5× 25 0.7× 10 582
Ivy I Boydstun United States 4 378 1.0× 114 0.4× 287 1.3× 101 1.1× 11 0.3× 7 507
Luigi Pusterla Italy 7 245 0.6× 138 0.5× 144 0.7× 92 1.0× 30 0.9× 8 366
Miwako Honda Japan 11 314 0.8× 113 0.4× 145 0.7× 181 1.9× 24 0.7× 20 456
Hiba Graham United States 10 318 0.8× 188 0.7× 185 0.8× 50 0.5× 109 3.1× 14 470

Countries citing papers authored by S Staszewski

Since Specialization
Citations

This map shows the geographic impact of S Staszewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Staszewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Staszewski more than expected).

Fields of papers citing papers by S Staszewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Staszewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Staszewski. The network helps show where S Staszewski may publish in the future.

Co-authorship network of co-authors of S Staszewski

This figure shows the co-authorship network connecting the top 25 collaborators of S Staszewski. A scholar is included among the top collaborators of S Staszewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Staszewski. S Staszewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
May, Margaret, Caroline Sabin, Geneviève Chêne, et al.. (2015). Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy. Open Access CRIS of the University of Bern.
2.
Stephan, Christoph, Markus Bickel, Annette Haberl, et al.. (2010). Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65R. Journal of Infection. 61(4). 346–350. 5 indexed citations
3.
Hentig, Nils von, Gaby Knecht, Amina Carlebach, et al.. (2008). The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors. Journal of Antimicrobial Chemotherapy. 62(3). 579–582. 26 indexed citations
4.
Salzberger, Bernd, Martin Däumer, Peter Gute, et al.. (2007). Consensus recommendation from a group of German experts for the use of enfuvirtide in heavily pretreated HIV patients.. PubMed. 12(3). 93–102. 3 indexed citations
5.
Rockstroh, Jürgen K., M. Vogel, Gerd Klausen, et al.. (2007). [636] THE INFLUENCE OF NUCLEOSIDE FREE HAART ON THE TREATMENT OF CHRONIC HEPATITIS C WITH PEGYLATED INTERFERON/RIBAVIRIN COMBINATION TREATMENT. Journal of Hepatology. 46. S240–S240. 1 indexed citations
6.
Izzedine, Hassane, Jean‐Sébastien Hulot, Daniel Vittecoq, et al.. (2005). Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. Nephrology Dialysis Transplantation. 20(4). 743–746. 144 indexed citations
7.
Hirsch, Martin, Roy T. Steigbigel, S Staszewski, et al.. (2003). Long-Term Efficacy, Safety, and Tolerability of Indinavir-Based Therapy in Protease Inhibitor--Naive Adults with Advanced HIV Infection. Clinical Infectious Diseases. 37(8). 1119–1124. 13 indexed citations
8.
Kurowski, Michael, et al.. (2002). Limited effect of food composition on the pharmacokinetics of nelfinavir administered twice daily.. PubMed. 7(10). 453–6. 3 indexed citations
9.
Phillips, AN, S Staszewski, Rainer Weber, et al.. (2000). Viral toad changes in response to antiretroviral therapy according to the baseline CD4 lymphocyte count and viral load. UCL Discovery (University College London). 3 indexed citations
10.
Rickerts, Volker, et al.. (2000). A case of lipodystrophy after the initiation of zidovudine, lamivudine and efavirenz in an asymptomatic HIV‐1‐infected patient. HIV Medicine. 1(3). 164–165. 2 indexed citations
11.
Brodt, HR, et al.. (2000). Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study.. PubMed. 5(8). 329–33. 119 indexed citations
12.
Scharl, Anton, et al.. (2000). Cervical intraepithelial neoplasia in human immunodeficiency virus-positive patients.. PubMed. 24(2). 179–85. 5 indexed citations
13.
Staszewski, S. (1999). Coming therapies: abacavir.. PubMed. 103. 35–8. 3 indexed citations
14.
Hirsch, Martin, Roy T. Steigbigel, S Staszewski, et al.. (1999). A Randomized, Controlled Trial of Indinavir, Zidovudine, and Lamivudine in Adults with Advanced Human Immunodeficiency Virus Type 1 Infection and Prior Antiretroviral Therapy. The Journal of Infectious Diseases. 180(3). 659–665. 86 indexed citations
15.
Staszewski, S. (1999). Update on study 006--EFV + AZT + 3TC versus the current 'standard of care' IDV + AZT + 3TC.. PubMed. 103. 10–5. 7 indexed citations
16.
Miller, et al.. (1999). Mega-HAART: preliminary results and correlation with baseline resistance.. PubMed. 4 Suppl 3. 93–4. 4 indexed citations
17.
Staszewski, S, et al.. (1993). [Epidemiology of tuberculosis in patients with HIV infection of the Frankfurt University Clinic].. PubMed. 88(5). 279–86. 3 indexed citations
18.
Ott, M., B. Lembcke, S Staszewski, E. B. Helm, & W. F. Caspary. (1991). Intestinale Permeabilität bei Patienten mit erworbenem Immundefekt — Syndrom (AIDS). Journal of Molecular Medicine. 69(15). 715–721. 13 indexed citations
19.
Norley, Stephen, et al.. (1990). Demonstration of cross-reactive antibodies able to elicit lysis of both HIV-1- and HIV-2-infected cells.. The Journal of Immunology. 145(6). 1700–1705. 19 indexed citations
20.
Staszewski, S, W. Stille, A Werner, Reinhard Kurth, & Karin Weber. (1987). [HIV-2 infection also in Germany].. PubMed. 112(12). 487–487. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amit C. Achhra Breakdown of academic impact, for papers by Maria Vittoria Cossu Breakdown of academic impact, for papers by Laurie Myers Breakdown of academic impact, for papers by Marilyn McMurchie Breakdown of academic impact, for papers by J.L. Pellegrin Breakdown of academic impact, for papers by Michael Giordano Breakdown of academic impact, for papers by Ivy I Boydstun Breakdown of academic impact, for papers by Luigi Pusterla Breakdown of academic impact, for papers by Miwako Honda Breakdown of academic impact, for papers by Hiba Graham
Rankless by CCL
2026